Publication:

The pathology and pathobiology of bicuspid aortic valve: State of the art and novel research perspectives†

Loading...
Thumbnail Image

Date

2015

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

John Wiley and Sons Inc.
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Mathieu, P., Y. Bossé, G. S. Huggins, A. D. Corte, P. Pibarot, H. I. Michelena, G. Limongelli, et al. 2015. “The pathology and pathobiology of bicuspid aortic valve: State of the art and novel research perspectives†.” The Journal of Pathology: Clinical Research 1 (4): 195-206. doi:10.1002/cjp2.21. http://dx.doi.org/10.1002/cjp2.21.

Abstract

Abstract Bicuspid aortic valve is the most prevalent cardiac valvular malformation. It is associated with a high rate of long‐term morbidity including development of calcific aortic valve disease, aortic regurgitation and concomitant thoracic aortic aneurysm and dissection. Recently, basic and translational studies have identified some key processes involved in the development of bicuspid aortic valve and its morbidity. The development of aortic valve disease and thoracic aortic aneurysm and dissection is the result of complex interactions between genotypes, environmental risk factors and specific haemodynamic conditions created by bicuspid aortic valve anatomy. Herein, we review the pathobiology of bicuspid aortic valve with a special emphasis on translational aspects of these basic findings. Important but unresolved problems in the pathology of bicuspid aortic valve and thoracic aortic aneurysm and dissection are discussed, along with the molecular processes involved.

Description

Research Data

Keywords

Review Article, bicuspid aortic valve, pathophysiology, calcific aortic valve disease, aorta dilation, thoracic aortic aneurysm

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories